Library / Blends / CJC-1295 + Ipamorelin

GHRH analog + GHRP · most common GH-axis blend

CJC-1295 + Ipamorelin

Blend

ClassTwo-peptide secretagogue blend
Typical routes in papersSC
Half-life contextShort if no-DAC CJC; ipamorelin short
EvidenceEach studied separately; blend is compounding / research-vial convention

What it is

The default “GH peptide blend” is CJC-1295 (almost always the no-DAC / Mod GRF 1-29 version) plus ipamorelin in one vial, often 5 mg + 5 mg or 10 mg total. Two doors into a GH pulse: GHRH receptor and ghrelin receptor.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Mod GRF / CJC-no-DAC amplifies a GHRH-style pulse. Ipamorelin triggers GHSR. Together they are the textbook secretagogue pair in community protocols.

Possible side effects / caveats

Water, tingling, tired-hungry if the GHRP share is high, and pituitary overuse talk if someone runs it without breaks. DAC version is a different kinetic.

Protocol ranges

Source tierAmountFrequency / durationNotes
Common vial5 mg CJC-no-DAC + 5 mg ipamorelinNightly mixed draw in citationsConfirm no-DAC
Cited pulse100–300 mcg of the mix per injection1–3× daily or bedtimeCommunity
See alsoCJC-1295 no DAC, Ipamorelin, CJC-1295 DACParts
Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.